查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1515507

非病毒转染试剂和系统市场，按类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Non-Viral Transfection Reagents and Systems Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年非病毒转染试剂和系统市场规模为 7.8623 亿美元，2024 年至 2032 年复合年增长率为 8.2%。

非病毒转染试剂与系统市场-市场动态

临床环境对非病毒转染试剂的需求正在推动其市场成长。

非病毒转染是现有方法的一种引人注目的替代方法，具有独特的优势。这些优势包括加快时间安排、提高生物效率、降低细胞毒性以及提供更多种核酸的能力。非病毒转染试剂在临床应用中的关键作用是其成长的关键驱动力。这些试剂有助于递送治疗性核酸，例如 siRNA、miRNA 和编码治疗性蛋白的 DNA 质粒或 CRISPR/Cas9 基因组编辑工具。这种能力为开发针对多种疾病的创新基因疗法铺平了道路，包括遗传性疾病、癌症和传染病。

目前的情况反映出许多公司积极开发先进的非病毒转染试剂和系统的活动激增。例如，最近，细胞治疗专家 BioCentriq 和 MIT 新创公司 Kytopen 联手开发创新的细胞治疗製造技术。

非病毒转染试剂与系统市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.2% 左右的复合年增长率成长

根据类型细分，预计非疾病转染试剂将在 2023 年显示最大的市场份额

从应用细分来看，2023年研究类应用为主导类型

根据最终用户细分，製药公司是 2023 年的主导类型

按地区划分，亚太地区是 2023 年的主要收入来源

非病毒转染试剂与系统市场区隔分析：

全球非病毒转染试剂和系统市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为三类：非病毒转染试剂、基于电穿孔的转染系统、其他非病毒转染系统。电穿孔涉及在核酸存在的情况下向细胞施加电脉衝，在细胞膜上形成临时孔，遗传物质可以通过该孔进入。电穿孔以其高转染效率而闻名，对于难以转染的细胞和原代细胞特别有效。它可用于瞬时和稳定转染，但需要专门的设备并针对不同细胞类型进行最佳化。

市场根据应用分为两类：临床和研究。基于非病毒转染试剂的研究涵盖了广泛的生物和生物医学领域。例如在基因功能研究中，研究人员使用非病毒转染试剂将特定基因或调控元件引入细胞中。这使他们能够研究基因表现模式、调控机制以及基因在各种细胞过程中的作用。

非病毒转染试剂与系统市场-地理洞察

由于研发方面的大量投资，亚太地区的生物技术和製药产业正在迅速扩张。这种成长在中国、日本和韩国等国家尤其明显。因此，对非病毒转染试剂的需求不断增加。这些试剂对于将遗传物质精确递送至目标细胞以及支持基因治疗和基因编辑技术的发展至关重要。此外，遗传性疾病盛行率的增加导致该地区生物医学研究和治疗进展对这些试剂的需求增加。例如，巴基斯坦人口组成的多样化，以显着的血缘关係为特征，导致遗传性疾病病例的盛行率较高。

非病毒转染试剂与系统市场竞争格局：

非病毒转染试剂和系统市场的一些主要参与者包括 Thermo Fisher Scientific、Bio-Rad Laboratories、Inovio Pharmaceuticals 和 MaxCyte。每个人都带来独特的技术和专业知识来推进涉及基因操作和细胞工程的研究和治疗应用。例如，MaxCyte 正在为原代细胞、干细胞和细胞系的瞬时和稳定转染提供可扩展的解决方案。 MaxCyte 的系统因其高转染效率、可扩展性以及在研究和临床环境中的适用性而受到重视。

Bio-Rad 实验室专注于基于电穿孔的转染系统，该系统透过施加电脉衝将核酸高效地输送到细胞中。 Bio-Rad 的系统广泛用于研究和生物製药应用中难以转染的细胞和原代细胞。

最近的发展：

2023 年 9 月，一家源自诺丁汉大学的新企业，与其合作伙伴诺丁汉大学一起，致力于开髮用于骨移植增强的干粉基因治疗配方，获得了英国创新机构 Innovate UK 的 995,000 英镑资助机构。

2023 年 8 月，Altogen Biosystems 推出了一种专注试剂，旨在将生物分子转运至肺部，用于治疗肺部疾病患者。该药物能够安全有效地将小分子、DNA、RNA 和蛋白质运送到肺部。

目录

第 1 章：非病毒转染试剂与系统市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的非病毒转染试剂和系统市场片段
    • 非病毒转染试剂和系统市场片段（依应用）
    • 最终用户的非病毒转染试剂和系统市场片段
    • 按国家/地区分類的非病毒转染试剂和系统市场片段
    • 按地区分類的非病毒转染试剂和系统市场片段
  • 竞争洞察

第 3 章：非病毒转染试剂与系统主要市场趋势

  • 非病毒转染试剂与系统市场驱动因素
    • 市场驱动因素的影响分析
  • 非病毒转染试剂与系统市场限制
    • 市场限制影响分析
  • 非病毒转染试剂和系统的市场机会
  • 非病毒转染试剂与系统市场未来趋势

第 4 章：非病毒转染试剂与系统产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：非病毒转染试剂与系统市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：非病毒转染试剂与系统市场格局

  • 2023 年非病毒转染试剂与系统市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：非病毒转染试剂和系统市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 非病毒转染试剂
    • 基于电穿孔的转染系统
    • 其他非病毒转染系统

第 8 章：非病毒转染试剂和系统市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 临床
    • 研究

第 9 章：非病毒转染试剂和系统市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 学术与研究
    • 製药公司
    • 其他的

第 10 章：非病毒转染试剂和系统市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美非病毒转染试剂和系统主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲非病毒转染试剂和系统主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区非病毒转染试剂和系统主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲非病毒转染试剂和系统主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲非病毒转染试剂和系统主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 非病毒转染试剂和系统产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific (TFS)
    • Lonza Group
    • Imunon (Formerly known as Celsion)
    • Promega Corporation
    • Altogen Biosystems
    • Mirus Bio LLC
    • Genprex
    • Polyplus-Transfection SA
    • Bio-Rad Laboratories
    • MaxCyte
    • MilliporeSigma
    • Qiagen
    • Takara Bio

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3258

REPORT HIGHLIGHT

Non-Viral Transfection Reagents and Systems Market size was valued at USD 786.23 Million in 2023, expanding at a CAGR of 8.2% from 2024 to 2032.

Non-viral transfection reagents are substances used in molecular biology and biotechnology to deliver genetic material (such as DNA or RNA) into cells without the use of viral vectors. They facilitate the introduction of nucleic acids into cells for various purposes, including gene expression studies, protein production, gene therapy, and genome editing.

Non-Viral Transfection Reagents and Systems Market- Market Dynamics

The need for Non-Viral Transfection Reagents in clinical settings is fueling their market growth.

Non-viral transfection is a compelling alternative to established methods, offering distinct advantages. These advantages include expedited timelines, enhanced biological efficiency, reduced cytotoxicity, and the ability to deliver a wider variety of nucleic acids. The pivotal role of non-viral transfection reagents in clinical applications is a key driver of their growth. These reagents facilitate the delivery of therapeutic nucleic acids, such as siRNA, miRNA, and DNA plasmids encoding therapeutic proteins or CRISPR/Cas9 genome editing tools. This capability paves the way for the development of innovative gene therapies for a broad spectrum of conditions, including genetic disorders, cancers, and infectious diseases.

The current landscape reflects a surge in activity by numerous companies actively developing advanced non-viral transfection reagents and systems. For example, recently, BioCentriq, a cell therapy expert, and Kytopen, an MIT startup, teamed up to develop innovative cell therapy manufacturing technology.

Non-Viral Transfection Reagents and Systems Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2024-2032)

Based on Type segmentation, non-viral transfection reagents were predicted to show maximum market share in the year 2023

Based on Application segmentation, Research Applications was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, Asia-Pacific was the leading revenue generator in 2023

Non-Viral Transfection Reagents and Systems Market- Segmentation Analysis:

The Global Non-Viral Transfection Reagents and Systems Market is segmented based on Type, Application, End User, and Region.

The market is divided into three categories based on Type: Non-Viral Transfection Reagents, Electroporation-based Transfection Systems and Other Non-Viral Transfection Systems. Electroporation involves applying electrical pulses to cells in the presence of nucleic acids, creating temporary pores in the cell membrane through which genetic material can enter. Electroporation is known for its high transfection efficiency and is particularly effective for difficult-to-transfect cells and primary cells. It can be used for transient and stable transfection but requires specialized equipment and optimization for different cell types.

The market is divided into two categories based on Application: Clinical and Research. Research based on non-viral transfection reagents spans a wide spectrum of biological and biomedical fields. Such as in gene function studies, researchers employ non-viral transfection reagents to introduce specific genes or regulatory elements into cells. This allows them to study gene expression patterns, regulatory mechanisms, and the roles of genes in various cellular processes.

Non-Viral Transfection Reagents and Systems Market- Geographical Insights

The biotechnology and pharmaceutical industries in the Asia-Pacific region are expanding swiftly due to substantial investments in research and development. This growth is particularly pronounced in countries such as China, Japan, and South Korea. As a result, there is an increasing need for non-viral transfection reagents. These reagents are crucial for delivering genetic material precisely to target cells and supporting the development of gene therapy and gene editing technologies. Moreover, the rising prevalence of genetic disorders is contributing to the heightened demand for these reagents in the region's biomedical research and therapeutic advancements. For instance, the diverse makeup of Pakistan's population, characterized by significant levels of consanguinity, contributes to the higher prevalence of genetic disorders cases.

Non-Viral Transfection Reagents and Systems Market- Competitive Landscape:

Some of the key players in the Non-Viral Transfection Reagent and Systems Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inovio Pharmaceuticals, and MaxCyte. Each brings unique technologies and expertise to advance research and therapeutic applications involving genetic manipulation and cell engineering. For example, MaxCyte, is offering scalable solutions for transient and stable transfection of primary cells, stem cells, and cell lines. MaxCyte's systems are valued for their high transfection efficiency, scalability, and applicability in research and clinical settings.

Bio-Rad Laboratories specialises in electroporation-based transfection systems, which offer high efficiency for delivering nucleic acids into cells by applying electrical pulses. Bio-Rad's systems are widely used for difficult-to-transfect cells and primary cells in research and biopharmaceutical applications.

Recent Developments:

In Sept 2023, A new enterprise stemming from the University of Nottingham, dedicated to advancing a dry powder gene therapy formulation for bone graft augmentation, along with its partner, the University of Nottingham, has been granted £995,000 by Innovate UK, the UK's innovation agency.

In August 2023, Altogen Biosystems introduced a focused reagent designed to transport biomolecules to the lungs for treating patients with pulmonary diseases. The drug has safely and effectively transported small molecules, DNA, RNA, and proteins to the lungs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (TFS)

Lonza Group

Imunon (Formerly known as Celsion)

Promega Corporation

Altogen Biosystems

Mirus Bio LLC

Genprex

Polyplus-Transfection SA

Bio-Rad Laboratories

MaxCyte

MilliporeSigma

Qiagen

Takara Bio

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Viral Transfection Reagents
  • Electroporation-based Transfection Systems
  • Other Non-Viral Transfection Systems

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Research

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Academic and Research
  • Pharmaceutical Companies
  • Others

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-Viral Transfection Reagents and Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-Viral Transfection Reagents and Systems Market Snippet by Type
    • 2.1.2. Non-Viral Transfection Reagents and Systems Market Snippet by Application
    • 2.1.3. Non-Viral Transfection Reagents and Systems Market Snippet by End User
    • 2.1.4. Non-Viral Transfection Reagents and Systems Market Snippet by Country
    • 2.1.5. Non-Viral Transfection Reagents and Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-Viral Transfection Reagents and Systems Key Market Trends

  • 3.1. Non-Viral Transfection Reagents and Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-Viral Transfection Reagents and Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-Viral Transfection Reagents and Systems Market Opportunities
  • 3.4. Non-Viral Transfection Reagents and Systems Market Future Trends

4. Non-Viral Transfection Reagents and Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-Viral Transfection Reagents and Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Non-Viral Transfection Reagents and Systems Market Landscape

  • 6.1. Non-Viral Transfection Reagents and Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-Viral Transfection Reagents and Systems Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Non-Viral Transfection Reagents
    • 7.1.3. Electroporation-based Transfection Systems
    • 7.1.4. Other Non-Viral Transfection Systems

8. Non-Viral Transfection Reagents and Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Research

9. Non-Viral Transfection Reagents and Systems Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Academic and Research
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Others

10. Non-Viral Transfection Reagents and Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Non-Viral Transfection Reagents and Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific (TFS)
    • 11.2.2. Lonza Group
    • 11.2.3. Imunon (Formerly known as Celsion)
    • 11.2.4. Promega Corporation
    • 11.2.5. Altogen Biosystems
    • 11.2.6. Mirus Bio LLC
    • 11.2.7. Genprex
    • 11.2.8. Polyplus-Transfection SA
    • 11.2.9. Bio-Rad Laboratories
    • 11.2.10. MaxCyte
    • 11.2.11. MilliporeSigma
    • 11.2.12. Qiagen
    • 11.2.13. Takara Bio

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Non-Viral Transfection Reagents and Systems Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Type 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Application 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by End User 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Region 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Non-Viral Transfection Reagents and Systems Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Germany Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE India Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Brazil Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Saudi Arabia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)